Cholesterol
FDA Extends Approval for Alirocumab to Lower LDL-C in Pediatric Patients with HeFHÂ
Addressing an Unmet Need in Pediatric Patients with HeFHÂ Heterozygous
April 19, 2024
Addressing an Unmet Need in Pediatric Patients with HeFHÂ Heterozygous
The U.S. Centers for Disease Control and Prevention (CDC) and
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
